Inflammation in Glaucoma: From the back to the front of the eye, and beyond

C Baudouin, M Kolko, S Melik-Parsadaniantz… - Progress in retinal and …, 2021 - Elsevier
The pathophysiology of glaucoma is complex, multifactorial and not completely understood.
Elevated intraocular pressure (IOP) and/or impaired retinal blood flow may cause initial optic …

Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists

J Sheppard, B Shen Lee, LM Periman - Annals of medicine, 2023 - Taylor & Francis
Dry eye disease (DED) is a multifactorial disorder characterized by loss of tear film
homeostasis with an estimated worldwide prevalence of 5% to 50%. In DED, dysfunction of …

Ocular surface disease and glaucoma medications: a clinical approach

X Zhang, S Vadoothker, WM Munir, O Saeedi - Eye & contact lens, 2019 - journals.lww.com
Objectives: Ocular surface disease frequently coexists with glaucoma and may be initiated
or exacerbated by topical glaucoma medications. We performed a review of current literature …

The Prevalence of Demodex Blepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic Sign

W Trattler, P Karpecki, Y Rapoport, E Sadri… - Clinical …, 2022 - Taylor & Francis
Purpose To evaluate the prevalence of Demodex blepharitis by its pathognomonic sign,
collarettes, in patients presenting for any reason to eye care clinics in the United States …

Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment

M Kolko, G Gazzard, C Baudouin, S Beier… - The ocular …, 2023 - Elsevier
Glaucoma is a common disease with an increasing prevalence [1]. Ocular surface disease
(OSD) is also common, and its prevalence is increasing [2, 3], due in part to the adverse …

[HTML][HTML] Understanding the dual dilemma of dry eye and glaucoma: an international review

LM Nijm, L De Benito-Llopis, GC Rossi… - Asia-Pacific Journal of …, 2020 - Elsevier
Glaucoma-related ocular surface disease (G-OSD) is a significant, yet often
underdiagnosed, ocular co-morbidity affecting 40% to 59% of glaucoma patients worldwide …

Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy

RE Ruiz-Lozano, NS Azar, HM Mousa… - Frontiers in …, 2023 - frontiersin.org
Ocular surface disease (OSD), a disorder affecting the lacrimal and meibomian glands and
the corneal and conjunctival epithelium, is a well-known complication of topical glaucoma …

Preservative-free prostaglandin analogs and prostaglandin/timolol fixed combinations in the treatment of glaucoma: efficacy, safety and potential advantages

G Holló, A Katsanos, KG Boboridis, M Irkec… - Drugs, 2018 - Springer
Glaucoma therapy-related ocular surface disease (OSD) is a serious pathology with a broad
spectrum of insidious clinical presentations and complex pathogenesis that undermines …

Ocular surface inflammation impairs structure and function of meibomian gland

S Mizoguchi, H Iwanishi, R Arita, K Shirai… - Experimental eye …, 2017 - Elsevier
Dysfunction of the meibomian glands alters secreted meibum quantitatively and qualitatively
that can lead to damage to the ocular surface epithelium. In response to an unstable tear film …

A narrative review of ocular surface disease related to anti-glaucomatous medications

X Zhou, X Zhang, D Zhou, Y Zhao, X Duan - Ophthalmology and Therapy, 2022 - Springer
Topical anti-glaucomatous medications are still the most important measure to lower
intraocular pressure. Large number of studies have confirmed that long-term use of anti …